Publications

PubMed Entries

Prof. Dr. Guus Rimmelzwaan

Dr. Amare Aregay

Dr. Sharmistha Dam

Dr. Thomas Gerlach

Prajeeth K. Chittappen, PhD

Husni Elbahesh, PhD

Giulietta Saletti, PhD

 

further Publications

Prof. Dr. Guus Rimmelzwaan

Sant, S., Quiñones-Parra, S. M., Koutsakos, M., Grant, E. J., Loudovaris, T., Mannering, S. I., Crowe, J., van de Sandt, C. E., Rimmelzwaan, G. F., Rossjohn, J., Gras, S., Loh, L., Nguyen, T. H. O., & Kedzierska, K. (2020). HLA-B*27:05 alters immunodominance hierarchy of universal influenza-specific CD8+ T cells. PLoS Pathogens, 16(8). https://doi.org/10.1371/journal.ppat.1008714
read more
Soilemetzidou, E.-S., De Bruin, E., Franz, M., Aschenborn, O. H. K., Rimmelzwaan, G. F., van Beek, R., Koopmans, M., Greenwood, A. D., & Czirják, G. Á. (2020). Diet may drive influenza A virus exposure in African mammals. The Journal of Infectious Diseases, 221(2), 175–182. https://doi.org/10.1093/infdis/jiz032
read more
Westerhuis, B., Ten Hulscher, H., Jacobi, R., van Beek, J., Koopmans, M., Rimmelzwaan, G., Meijer, A., & van Binnendijk, R. (2020). Specific memory B cell response in humans upon infection with highly pathogenic H7N7 avian influenza virus. Scientific Reports, 10: 3152. https://doi.org/10.1038/s41598-020-60048-9
read more
Wilken, L., & Rimmelzwaan, G. F. (2020). Adaptive Immunity to dengue virus: Slippery slope or solid ground for rational vaccine design? Pathogens, 9(6:470). https://doi.org/10.3390/pathogens9060470
read more
Wilken, L., Stanelle-Betram, S., Pinho dos Reis, V., Gerlach, T., Gabriel, G., & Rimmelzwaan, G. (2020). An influenza A virus–based vaccine candidate expressing Zika virus envelope protein domain III. In Stiftung Tierärztliche Hochschule Hannover (Ed.), 13th Graduate School Days: 20/21 November 2020 / Stiftung Tierärztliche Hochschule Hannover. Stiftung Tierärztliche Hochschule Hannover.
read more
de Vries, R. D., Nieuwkoop, N. J., Krammer, F., Hu, B., & Rimmelzwaan, G. F. (2020). Analysis of the vaccine-induced influenza B virus hemagglutinin-specific antibody dependent cellular cytotoxicity response. Virus Research: An International Journal of Molecular and Cellular Virology, 277: 197839. https://doi.org/10.1016/j.virusres.2019.197839
read more
Elbahesh, H., Gerlach, T., Saletti, G., & Rimmelzwaan, G. F. (2019). Response modifiers: tweaking the immune response against influenza A virus. Frontiers in Immunology, 10: 809. https://doi.org/10.3389/fimmu.2019.00809
read more
Elbahesh, H., Saletti, G., Gerlach, T., & Rimmelzwaan, G. F. (2019). Broadly protective influenza vaccines: design and production platforms. Current Opinion in Virology, 34, 1–9. https://doi.org/10.1016/j.coviro.2018.11.005
read more
Gerlach, T., Elbahesh, H., Saletti, G., & Rimmelzwaan, G. F. (2019). Recombinant influenza A viruses as vaccine vectors. Expert Review of Vaccines, 18(4), 379–392. https://doi.org/10.1080/14760584.2019.1582338
read more
Jansen, J. M., Gerlach, T., Elbahesh, H., Rimmelzwaan, G. F., & Saletti, G. (2019). Influenza virus-specific CD4+ and CD8+ T cell-mediated immunity induced by infection and vaccination. Journal of Clinical Virology, 119, 44–52. https://doi.org/10.1016/j.jcv.2019.08.009
read more

Prajeeth K. Chittappen, PhD

Pars, K., Gingele, M., Kronenberg, J., Prajeeth, C. K., Skripuletz, T., Pul, R., Jacobs, R., Gudi, V., & Stangel, M. (2019). Fumaric acids do not directly influence gene expression of neuroprotective factors in highly purified rodent astrocytes. Brain Sciences, 9(9: 241). https://doi.org/10.3390/brainsci9090241
read more

Husni Elhabesh, PhD

Elbahesh, H., Gerlach, T., Saletti, G., & Rimmelzwaan, G. F. (2019). Response modifiers: tweaking the immune response against influenza A virus. Frontiers in Immunology, 10: 809. https://doi.org/10.3389/fimmu.2019.00809
read more
Elbahesh, H., Saletti, G., Gerlach, T., & Rimmelzwaan, G. F. (2019). Broadly protective influenza vaccines: design and production platforms. Current Opinion in Virology, 34, 1–9. https://doi.org/10.1016/j.coviro.2018.11.005
read more
Gerlach, T., Elbahesh, H., Saletti, G., & Rimmelzwaan, G. F. (2019). Recombinant influenza A viruses as vaccine vectors. Expert Review of Vaccines, 18(4), 379–392. https://doi.org/10.1080/14760584.2019.1582338
read more
Jansen, J. M., Gerlach, T., Elbahesh, H., Rimmelzwaan, G. F., & Saletti, G. (2019). Influenza virus-specific CD4+ and CD8+ T cell-mediated immunity induced by infection and vaccination. Journal of Clinical Virology, 119, 44–52. https://doi.org/10.1016/j.jcv.2019.08.009
read more
Meineke, R., Rimmelzwaan, G. F., & Elbahesh, H. (2019). Influenza virus infections and cellular kinases. Viruses, 11(2: 171). https://doi.org/10.3390/v11020171
read more
Meineke, R., Rimmelzwaan, G. F., & Elbahesh, H. (2019). In vitro analysis of specific kinases on Influenza A virus infection. In Stiftung Tierärztliche Hochschule Hannover (Ed.), 12th Graduate School Days: 29/30 November 2019 / Stiftung Tierärztliche Hochschule Hannover. Stiftung Tierärztliche Hochschule Hannover.
read more